146 related articles for article (PubMed ID: 8014509)
1. High-dose fluconazole for treatment of cryptococcal disease in patients with human immunodeficiency virus infection. The California Collaborative Treatment Group.
Haubrich RH; Haghighat D; Bozzette SA; Tilles J; McCutchan JA
J Infect Dis; 1994 Jul; 170(1):238-42. PubMed ID: 8014509
[TBL] [Abstract][Full Text] [Related]
2. High-dose fluconazole therapy for cryptococcal meningitis in patients with AIDS.
Menichetti F; Fiorio M; Tosti A; Gatti G; Bruna Pasticci M; Miletich F; Marroni M; Bassetti D; Pauluzzi S
Clin Infect Dis; 1996 May; 22(5):838-40. PubMed ID: 8722942
[TBL] [Abstract][Full Text] [Related]
3. A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. California Collaborative Treatment Group.
Bozzette SA; Larsen RA; Chiu J; Leal MA; Jacobsen J; Rothman P; Robinson P; Gilbert G; McCutchan JA; Tilles J
N Engl J Med; 1991 Feb; 324(9):580-4. PubMed ID: 1992319
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of fluconazole in cryptococcal meningitis.
Jones PD; Marriott D; Speed BR
Diagn Microbiol Infect Dis; 1989; 12(4 Suppl):235S-238S. PubMed ID: 2556240
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of fluconazole 600 mg/day versus itraconazole 600 mg/day as consolidation therapy of cryptococcal meningitis in AIDS patients.
Mootsikapun P; Chetchotisakd P; Anunnatsiri S; Choksawadphinyo K
J Med Assoc Thai; 2003 Apr; 86(4):293-8. PubMed ID: 12757072
[TBL] [Abstract][Full Text] [Related]
6. Amphotericin B as primary therapy for cryptococcosis in patients with AIDS: reliability of relatively high doses administered over a relatively short period.
de Lalla F; Pellizzer G; Vaglia A; Manfrin V; Franzetti M; Fabris P; Stecca C
Clin Infect Dis; 1995 Feb; 20(2):263-6. PubMed ID: 7742427
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group.
van der Horst CM; Saag MS; Cloud GA; Hamill RJ; Graybill JR; Sobel JD; Johnson PC; Tuazon CU; Kerkering T; Moskovitz BL; Powderly WG; Dismukes WE
N Engl J Med; 1997 Jul; 337(1):15-21. PubMed ID: 9203426
[TBL] [Abstract][Full Text] [Related]
8. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.
Saag MS; Powderly WG; Cloud GA; Robinson P; Grieco MH; Sharkey PK; Thompson SE; Sugar AM; Tuazon CU; Fisher JF
N Engl J Med; 1992 Jan; 326(2):83-9. PubMed ID: 1727236
[TBL] [Abstract][Full Text] [Related]
9. The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection.
Nelson MR; Fisher M; Cartledge J; Rogers T; Gazzard BG
AIDS; 1994 May; 8(5):651-4. PubMed ID: 8060545
[TBL] [Abstract][Full Text] [Related]
10. Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America.
Saag MS; Graybill RJ; Larsen RA; Pappas PG; Perfect JR; Powderly WG; Sobel JD; Dismukes WE
Clin Infect Dis; 2000 Apr; 30(4):710-8. PubMed ID: 10770733
[TBL] [Abstract][Full Text] [Related]
11. Initial therapy for acquired immunodeficiency syndrome-associated cryptococcosis with fluconazole.
Nightingale SD
Arch Intern Med; 1995 Mar; 155(5):538-40. PubMed ID: 7864710
[TBL] [Abstract][Full Text] [Related]
12. Parenteral and oral fluconazole for acute cryptococcal meningitis in AIDS: experience with thirteen patients.
Stern JJ; Pietroski NA; Buckley RM; Braffman MN; Rinaldi MG
Ann Pharmacother; 1992; 26(7-8):876-82. PubMed ID: 1504391
[TBL] [Abstract][Full Text] [Related]
13. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.
Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS
Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774
[TBL] [Abstract][Full Text] [Related]
14. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
Saag MS; Cloud GA; Graybill JR; Sobel JD; Tuazon CU; Johnson PC; Fessel WJ; Moskovitz BL; Wiesinger B; Cosmatos D; Riser L; Thomas C; Hafner R; Dismukes WE
Clin Infect Dis; 1999 Feb; 28(2):291-6. PubMed ID: 10064246
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of disseminated cryptococcosis in a liver transplant recipient with fluconazole and flucytosine, an all oral regimen.
Singh N; Gayowski T; Marino IR
Transpl Int; 1998; 11(1):63-5. PubMed ID: 9503557
[TBL] [Abstract][Full Text] [Related]
16. Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis.
Powderly WG; Cloud GA; Dismukes WE; Saag MS
Clin Infect Dis; 1994 May; 18(5):789-92. PubMed ID: 8075272
[TBL] [Abstract][Full Text] [Related]
17. Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS.
Larsen RA; Bozzette SA; Jones BE; Haghighat D; Leal MA; Forthal D; Bauer M; Tilles JG; McCutchan JA; Leedom JM
Clin Infect Dis; 1994 Oct; 19(4):741-5. PubMed ID: 7803641
[TBL] [Abstract][Full Text] [Related]
18. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group.
Powderly WG; Saag MS; Cloud GA; Robinson P; Meyer RD; Jacobson JM; Graybill JR; Sugar AM; McAuliffe VJ; Follansbee SE
N Engl J Med; 1992 Mar; 326(12):793-8. PubMed ID: 1538722
[TBL] [Abstract][Full Text] [Related]
19. Cryptococcosis.
Powderly WG
J Int Assoc Physicians AIDS Care; 1996 Jul; 2(7):28-31. PubMed ID: 11363741
[TBL] [Abstract][Full Text] [Related]
20. [Successful discontinuation of antifungal secondary prophylaxis in AIDS-related cryptococcosis].
Negroni R; Helou SH; López Daneri G; Robles AM; Arechavala AI; Bianchi MH
Rev Argent Microbiol; 2004; 36(3):113-7. PubMed ID: 15559192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
